EyePoint Pharmaceuticals
EYPT
#10613
Rank
A$40.25 M
Marketcap
A$0.35
Share price
-11.36%
Change (1 day)
-98.33%
Change (1 year)

EPS for EyePoint Pharmaceuticals (EYPT)

EPS in 2026 (TTM): A-$5.50

According to EyePoint Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$5.65. In 2025 the company made an earnings per share (EPS) of A-$4.77 a decrease over its 2024 EPS that were of A-$3.49.

EPS history for EyePoint Pharmaceuticals from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.5015.25%
2025A-$4.7736.8%
2024A-$3.49
2022A-$4.1235.15%
2021A-$3.05-42.45%
2020A-$5.30-37.32%
2019A-$8.46-57.89%
2018A-$20.09125.42%
2017A-$8.916.89%
2016A-$8.34-20.01%
2015A-$10.42
2013A-$8.4621.74%
2012A-$6.95-58.18%
2011A-$16.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
A-$0.09065-98.40% Bahamas
NRC Health
NRC
A$0.44-107.75%๐Ÿ‡บ๐Ÿ‡ธ USA